TARGETING DORMANT BACILLI TO FIGHT TUBERCULOSIS

TARGETING DORMANT BACILLI TO FIGHT TUBERCULOSIS

Tuberculosis (TB) is an infectious disease caused by Mycobacterium tuberculosis (Mtb), which kills about 2 million people annually. Furthermore, 2 billion people worldwide are latently infected with this organism, with 10% of them reactivating to active TB due to re-growth of nonreplicating (dormant...

Full description

Bibliographic Details
Main Authors:	Lanfranco Fattorini, Giovanni Piccaro, Alessandro Mustazzolu, Federico Giannoni
Format:	Article
Language:	English
Published:	Mattioli1885 2013-11-01
Series:	Mediterranean Journal of Hematology and Infectious Diseases
Subjects:	Tuberculosis, Mycobacterium tuberculois, anti-TB drugs, dormancy.
Online Access:	http://www.mjhid.org/index.php/mjhid/article/view/426

Similar Items

Fighting tuberculosis by drugs targeting nonreplicating Mycobacterium tuberculosis bacilli
by: Angelo Iacobino, et al.
Published: (2017-01-01)

Tuberculosis: The success tale of less explored dormant Mycobacterium tuberculosis
by: Akanksha Verma, et al.
Published: (2022-12-01)

Mycobacterium tuberculosis thymidylate kinase antigen assays for designating incipient, high-risk latent M.tb infection
by: Misaki Wayengera, et al.
Published: (2018-03-01)

Activity of drugs against dormant Mycobacterium tuberculosis
by: A Iacobino, et al.
Published: (2016-01-01)

Targeting dormant phenotype acquired mycobacteria using natural products by exploring its important targets: In vitro and in silico studies
by: Shweta Sharma, et al.
Published: (2023-03-01)

Drug-Resistant Tuberculosis 2020: Where We Stand
by: Angelo Iacobino, et al.
Published: (2020-03-01)

Comparing pili producing gene (mtp-flp) in susceptible and resistant dormant Mycobacterium tuberculosis strains with active clinical isolates
by: Zahra Nasirzadeh, et al.
Published: (2022-01-01)

Moxifloxacin Activates the SOS Response in <i>Mycobacterium tuberculosis</i> in a Dose- and Time-Dependent Manner
by: Angelo Iacobino, et al.
Published: (2021-01-01)

Croup syndrome and primary infection with mycobacterium tuberculosis in children
by: L. I. Mozzhukhina, et al.
Published: (2019-02-01)

Coupling reporter expression to respiration detects active as well as dormant mycobacteria in vitro and in mouse tissues
by: Subash Chand Verma, et al.
Published: (2014-01-01)

The role of mycobacterium tuberculosis antigen specific cytokines in determination of acid fast bacilli culture status in pulmonary tuberculosis patients co-infected with human immunodeficiency virus
by: Job Kisuya, et al.
Published: (2018-11-01)

Eradication of Drug-Tolerant <i>Mycobacterium tuberculosis</i> 2022: Where We Stand
by: Alessio Lanni, et al.
Published: (2023-06-01)

Do we need a new Fleming époque: The nightmare of drug-resistant tuberculosis
by: Giovanni Sotgiu, et al.
Published: (2013-01-01)

Plasma Levels of Cytokines (IL-10, IFN-γ and TNF-α) in Multidrug Resistant Tuberculosis and Drug Responsive Tuberculosis Patients in Ghana
by: Anthony Basingnaa, et al.
Published: (2018-12-01)

Sudapyridine (WX-081), a Novel Compound against Mycobacterium tuberculosis
by: Rong Yao, et al.
Published: (2022-02-01)

Genetic factors affecting storage and utilization of lipids during dormancy in Mycobacterium tuberculosis
by: Alexander Sturm, et al.
Published: (2024-02-01)

Pretomanid for tuberculosis treatment: an update for clinical purposes
by: Sara Occhineri, et al.
Published: (2022-01-01)

Mycobacterium tuberculosis and SARS-CoV-2 Coinfections: A Review
by: Narjess Bostanghadiri, et al.
Published: (2022-02-01)

<i>Mycobacterium tuberculosis</i> Dormancy: How to Fight a Hidden Danger
by: Elena G. Salina, et al.
Published: (2022-11-01)

Application Values of T-SPOT.TB in Clinical Rapid Diagnosis of Tuberculosis
by: Feng ZHU, et al.
Published: (2017-12-01)

Applications of Transcriptomics and Proteomics for Understanding Dormancy and Resuscitation in Mycobacterium tuberculosis
by: Manikuntala Kundu, et al.
Published: (2021-03-01)

Co-infection of long-standing extensively drug-resistant Mycobacterium tuberculosis (XDR-TB) and non-tuberculosis mycobacteria: A case report
by: Nafiseh Izadi, et al.
Published: (2015-01-01)

Phenotypic and genotypic variant of MDR-Mycobacterium tuberculosis multiple isolates in the same tuberculosis episode, Rio de Janeiro, Brazil
by: M.K.N. Andrade, et al.
Published: (2009-05-01)

Mechanism of Action, Resistance, Synergism, and Clinical Implications of Delamanid Against Multidrug-Resistant Mycobacterium tuberculosis
by: Saeed Khoshnood, et al.
Published: (2021-10-01)

Knowledge about Tuberculosis of Peoples Living in Eastern Part of Nepal
by: Ram Hari Ghimire, et al.
Published: (2013-10-01)

Pattern of drug resistance of Mycobacterium tuberculosis clinical isolates to first-line antituberculosis drugs in pulmonary cases
by: Deepika Kalo, et al.
Published: (2015-01-01)

Plasma Eicosanoid Levels in Tuberculosis and Tuberculosis-Diabetes Co-morbidity Are Associated With Lung Pathology and Bacterial Burden
by: Nathella Pavan Kumar, et al.
Published: (2019-10-01)

Ertapenem and Faropenem against Mycobacterium tuberculosis: in vitro testing and comparison by macro and microdilution
by: Ximena Gonzalo, et al.
Published: (2020-08-01)

Tuberculosis control by novel vaccines development and Indian initiatives
by: Prasanta Kumar Ghosh
Published: (2023-01-01)

Genotypic and phenotypic characterization of Mycobacterium tuberculosis resistance against fluoroquinolones in the northeast of Iran
by: Mahdieh Sayadi, et al.
Published: (2020-06-01)

Tween 80 Improves the Acid-Fast Bacilli Quantification in the Magnetic Nanoparticle-Based Colorimetric Biosensing Assay (NCBA)
by: Cristina Gordillo-Marroquín, et al.
Published: (2022-01-01)

Prevalence and Drug Resistance Pattern of Mycobacterium tuberculosis Isolated from Tuberculosis Patients in Basra, Iraq
by: Mohammed Khairallah A.S., et al.
Published: (2022-05-01)

Multidrug resistant tuberculosis in HIV positive patients and its effect on Interleukin-2 and Interferon-γ
by: Abdulahi Isiyaku, et al.
Published: (2022-08-01)

Multifaceted remodeling by vitamin C boosts sensitivity of Mycobacterium tuberculosis subpopulations to combination treatment by anti-tubercular drugs
by: Kriti Sikri, et al.
Published: (2018-05-01)

Multidrug-resistant tuberculosis: case reports study in a central state of Brazil
by: João Alves de Araújo-Filho, et al.

Targeting Non-Replicating <i>Mycobacterium tuberculosis</i> and Latent Infection: Alternatives and Perspectives (Mini-Review)
by: Anna Egorova, et al.
Published: (2021-12-01)

Drug resistance profiles and trends in drug-resistant tuberculosis at a major hospital in Guizhou Province of China
by: Lan YB, et al.
Published: (2019-01-01)

Ocular manifestations and diagnosis of tuberculosis involving the uvea: a case series
by: Jennifer KS Tsui, et al.
Published: (2023-11-01)

Increase in Tuberculosis Cases among Prisoners, Brazil, 2009–2014
by: Paul M. Bourdillon, et al.
Published: (2017-03-01)

Mycobacterium tuberculosis Beijing Genotype, Thailand—Reply to Dr. Prodinger
by: Dick van Soolingen, et al.
Published: (2001-08-01)